MedTrace Logo

First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study

NCT00537901 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2015-12-17

No results posted yet for this study

Summary

First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum

Conditions

  • Colonic Neoplasms
  • Rectal Neoplasms

Interventions

RADIATION

First-Line Bevacizumab and Chemotherapy

Chemotherapy

DRUG

Bevacizumab

Chemotherapy

Sponsors & Collaborators

  • King Faisal Specialist Hospital & Research Center

    lead OTHER

Principal Investigators

  • Shouki Bazarbashi, MD · KFSH & RC

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2013-10-31
Completion
2013-10-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00537901 on ClinicalTrials.gov